Haemonetics (NYSE: HAE) reported Q2 EPS of $0.62, $0.11 better than the analyst estimate of $0.51. Revenue for the quarter came in at $209 million versus the consensus estimate of $207.65 million.

Link to 2Q Earnings Release

For earnings history and earnings-related data on Haemonetics (HAE) click here.